# Ministry of Health, Labour and Welfare (Japan)

Type: organization

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/ministry-of-health-labour-and-welfare-japan
Canonical HTML page: https://gethealthbrief.com/entity/ministry-of-health-labour-and-welfare-japan

## Timeline

- **2026-03-06**: Regulatory Approval — Japan's Ministry of Health officially approves the therapy for clinical use.
- **2024-11-15**: Data Submission — Sumitomo Pharma submits trial data to Japan's PMDA for regulatory review.
- **2018-08-01**: Clinical Trial Launch — Kyoto University begins the first human clinical trial for iPS-derived Parkinson's treatment.
- **2012-10-08**: Nobel Prize Awarded — Shinya Yamanaka wins the Nobel Prize for the discovery of iPS cells.

## Recent coverage (1 stories)

### Japan Approves World-First iPS Stem-Cell Therapy for Parkinson’s Disease
2026-03-06 07:54:19 · Sentiment: Strongly positive · Impact: 9/10 · Sources: 3

Japan's Ministry of Health has granted regulatory approval for a groundbreaking stem-cell treatment for Parkinson's disease, marking the first time induced pluripotent stem cells (iPS) have been cleared for clinical use. The therapy, developed by Kyoto University and Sumitomo Pharma, aims to restore dopamine-producing neurons in the brain.
Full story: https://gethealthbrief.com/story/japan-approves-world-first-ips-stem-cell-parkinsons-treatment

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.